Tadashi Shimizu Selected Research

Tadashi Shimizu Research Topics

Disease

21	Neoplasms (Cancer) 04/2024 - 03/2002
16	Drug-Related Side Effects and Adverse Reactions 04/2024 - 01/2022
8	Multiple Myeloma 10/2023 - 01/2022
7	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 03/2002
5	Necrosis 03/2018 - 07/2014
5	Stomach Neoplasms (Stomach Cancer) 12/2015 - 01/2013
5	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 10/2007
4	Lung Neoplasms (Lung Cancer) 06/2022 - 01/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 08/2022 - 03/2005
3	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2022 - 06/2022
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2013
3	Pain (Aches) 01/2017 - 04/2012
3	Kidney Neoplasms (Kidney Cancer) 12/2014 - 01/2013
3	Malignant Mesothelioma 12/2014 - 01/2013
2	Hematologic Diseases (Blood Diseases) 05/2023 - 12/2022
2	Heart Failure 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 07/2022 - 06/2022
2	Infections 12/2021 - 12/2015
2	Leiomyoma (Uterine Fibroids) 11/2010 - 07/2006
2	Pneumothorax 08/2009 - 12/2002
1	Stomatitis 01/2024
1	Embolism and Thrombosis 05/2023
1	Thromboembolism 05/2023
1	Pericardial Effusion 03/2023
1	Myocarditis (Carditis) 03/2023
1	Mpox (monkeypox) 02/2023
1	Nausea 02/2023
1	Coronavirus Infections 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	COVID-19 01/2023
1	Atrial Fibrillation 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Breast Neoplasms (Breast Cancer) 08/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022
1	Small Cell Carcinoma 07/2022
1	Lung Diseases (Lung Disease) 07/2022
1	Shoulder Pain 06/2022
1	Pulmonary Edema 06/2022
1	Exanthema (Rash) 05/2022

Drug/Important Bio-Agent (IBA)

5	naftopidilIBA 01/2020 - 01/2013
5	1- (2- (2- methoxyphenylamino)ethylamino)- 3- (naphthalene- 1- yloxy)propan- 2- olIBA 01/2016 - 01/2013
3	Proteasome InhibitorsIBA 01/2023 - 01/2022
3	GoldIBA 05/2003 - 03/2002
2	pembrolizumabIBA 04/2024 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2024 - 07/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2024 - 05/2023
2	Lenalidomide (CC 5013)FDA Link 05/2023 - 12/2022
2	NivolumabIBA 03/2023 - 01/2023
2	carfilzomibIBA 01/2023 - 01/2022
2	Bortezomib (Velcade)FDA Link 01/2023 - 01/2022
2	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2017
2	Dihydrotachysterol (AT 10)IBA 01/2018 - 01/2017
2	Caspase 3 (Caspase-3)IBA 01/2016 - 01/2013
2	Propidium (Propidium Iodide)IBA 01/2016 - 03/2015
2	Annexin A5IBA 01/2016 - 03/2015
2	Cisplatin (Platino)FDA LinkGeneric 03/2015 - 07/2014
2	CaspasesIBA 03/2015 - 05/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2015 - 07/2014
2	IceIBA 10/2014 - 07/2006
2	8- (2- (2- pentyl- cyclopropylmethyl)cyclopropyl)octanoic acidIBA 07/2012 - 01/2011
2	Ethanol (Ethyl Alcohol)IBA 04/2012 - 02/2008
1	ErbB Receptors (EGF Receptor)IBA 01/2024
1	MTOR InhibitorsIBA 01/2024
1	Tyrosine Kinase InhibitorsIBA 01/2024
1	AntibodiesIBA 01/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024
1	daratumumabIBA 10/2023
1	AnticoagulantsIBA 05/2023
1	pomalidomideIBA 03/2023
1	Alanine Transaminase (SGPT)IBA 02/2023
1	tecovirimatIBA 02/2023
1	Cidofovir (Vistide)FDA Link 02/2023
1	brincidofovirIBA 02/2023
1	Antiviral Agents (Antivirals)IBA 02/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	nilotinib FDA Link 01/2023
1	ponatinibIBA 01/2023
1	VaccinesIBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	Trastuzumab (Herceptin)FDA Link 09/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2022
1	Everolimus FDA Link 08/2022
1	Blood Glucose (Blood Sugar)IBA 08/2022
1	Monoclonal AntibodiesIBA 07/2022
1	durvalumabIBA 07/2022
1	LigandsIBA 07/2022
1	Anaplastic Lymphoma KinaseIBA 06/2022
1	alectinibIBA 06/2022
1	Bendamustine Hydrochloride FDA Link 05/2022

Therapy/Procedure

9	Therapeutics 02/2023 - 06/2010
6	Cryosurgery 09/2016 - 03/2005
5	Aftercare (After-Treatment) 07/2022 - 06/2004
4	Radiotherapy 10/2007 - 03/2002
2	Hepatectomy 04/2012 - 05/2003
2	Particle Accelerators 05/2003 - 03/2002
1	Oral Administration 02/2023
1	Decompression 06/2022
1	Debridement 06/2022